Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Gwolf who wrote (691)	6/21/1998 12:44:00 PM
From: electra	Read Replies (2) \| Respond to of 6039

gwolf, When was the article in the NY Times? Interesting points. What do you think about the prices of those companies? I have been following this thread for awhile and considering buying COII. As a woman, I know we need to find an alternative to mammograms. Many women I know have had to had biopsies which turn out negative. This creates stress for the woman plus expense for the HMO and/or insurance comp. But, if they have spent money on new mammogram equipment, are they quickly going turn and spend money on different systems? Thanks, Electra

To: Gwolf who wrote (691)	6/21/1998 12:53:00 PM
From: Mr. K	Read Replies (1) \| Respond to of 6039

Mr. Packer, or the publisher, failed to mention that CTI was in clinical trials? I would think that information would be important to potential new investors?

To: Gwolf who wrote (691)	6/21/1998 6:15:00 PM
From: chirodoc	Respond to of 6039

<<<<<It is interesting to note that Caprius had a high of 83 3/4 in late 1993 and stands today at their low of 1 1/2. IMDS had a high of 4 1/4 in March of 1997 and is now at their low of .43 cents. COII had a high of 3 1/4 in May of 1995 with the low recently at .47 cents and it's now at 1.05. ........they should all pop a bit on this news ........wait till everyone learns about the accuracy of cti. ......it will look more like sonus than the above is my guess. curtis

To: Gwolf who wrote (691)	6/22/1998 9:42:00 AM
From: DrDave	Read Replies (1) \| Respond to of 6039

<<<it is interesting to note Gwolf, could you please clarify your point with your analogy behind the stock prices of the three companies. From a medical point of view it is my understanding that caprius tanked because the enormous cost of MRI scanners far out weighed the false positives of mammography, and the third company has not even started any clinical trials as of yet. It seems that CTI is on a completely different playing field because 1: their clinical trials are almost over and 2: there will be little problem with cost if the units (they will be leased) or the cost of the procedure. I see no comparison in any of these companies nor the run of their stock prices.